Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,978
Total Claims
$882K
Drug Cost
915
Beneficiaries
$964
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-30%
Opioid rate vs peers
1.7% vs 2.5% avg
-15%
Cost per patient vs peers
$964 vs $1,128 avg
+14%
Brand preference vs peers
9.6% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.7%
Opioid Rate
189
Opioid Claims
$1,336
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,040 claims · $700K
Generic: 9,810 claims · $173K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | 34 | $154K |
| Apixaban | 62 | $65K |
| Insulin Glargine,hum.Rec.Anlog | 52 | $45K |
| Semaglutide | 39 | $44K |
| Dulaglutide | 15 | $30K |
| Sitagliptin Phosphate | 24 | $29K |
| Empagliflozin | 15 | $23K |
| Rivaroxaban | 21 | $23K |
| Dapagliflozin Propanediol | 18 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $18K |
| Linaclotide | 16 | $14K |
| Insulin Nph Hum/Reg Insulin Hm | 35 | $14K |
| Budesonide/Formoterol Fumarate | 29 | $12K |
| Fluticasone/Umeclidin/Vilanter | 14 | $9,580 |
| Albuterol Sulfate | 250 | $9,366 |
Prescribing Profile
Patient Profile
71
Avg Age
64%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data